Colon cancer, illustration
A blood test for bowel cancer developed by researchers in Dublin is being backed with a €670,000 fund in a bid to make it a commercially viable product.
Researchers from Trinity College Dublin and Dublin City University will use newly awarded funding from Enterprise Ireland’s Commercialisation Fund to develop a blood-based screening test.